Showing results (641-650 of 2,117) with videos related to

Sort By:
Pageof 212
International Clinical Psychopharmacology|April 1, 1990
Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patientsE Widerlöv, G Franzén, P Jansson, et al.
International Clinical Psychopharmacology|August 27, 2009
Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction QuestionnaireKathleen Wyrwich, Neesha Harnam, Dennis A Revicki, et al.
International Clinical Psychopharmacology|March 12, 2011
Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-upHendrik van den Bussche, Hanna Kaduszkiewicz, Daniela Koller, et al.
International Clinical Psychopharmacology|July 1, 1997
Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot studyR Zanardi, L Franchini, M Gasperini, et al.
International Clinical Psychopharmacology|July 1, 1997
The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapyB R Miljković, M Pokrajac, I Timotijević, et al.
International Clinical Psychopharmacology|July 1, 1997
Incidence of antidepressant drug use in older adults and association with chronic diseases: the Rotterdam StudyA C Egberts, H G Leufkens, A Hofman, et al.
International Clinical Psychopharmacology|July 1, 1997
Fast-onset antidepressantsS A Montgomery
International Clinical Psychopharmacology|July 1, 1997
The mesolimbic dopamine system as a target for rapid antidepressant actionP Willner
International Clinical Psychopharmacology|July 1, 1997
Pharmacology of amineptine, an antidepressant agent acting on the dopaminergic system: a reviewS Garattini
International Clinical Psychopharmacology|July 1, 1997
The efficacy and acceptability of amineptine versus fluoxetine in major depressionJ Dalery, C Rochat, E Peyron, et al.
Pageof 212